Coverage
-
December 14, 2016
A New Jersey federal judge on Tuesday dismissed with prejudice Endo Pharmaceuticals Inc.'s false marketing lawsuit against Actavis Inc. in the wake of a related patent infringement judgment in New York federal court that bars Actavis from selling a generic version of Endo's painkiller Opana ER.
4 other articles on this case.
View all »